From: Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study
Character | Range | |
Screened patients | 65 | |
Recruited patients | 32 | |
Female | 14 | |
Male | 18 | |
Age | 62 years | [47-75] |
Histology | pancreatic adenocarcinoma | |
Metastatic disease | 32 | |
Median BMI | 19.7 kg/m2 | [14.4 to 25.0] |
Median Phase angle | 3.6° | [2.3 to 5.1] |
Median ECM/BCM index | 1.7 | [1.1 to 3.1] |